Filing Details

Accession Number:
0001261380-13-000009
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-14 17:39:43
Reporting Period:
2013-02-12
Filing Date:
2013-02-14
Accepted Time:
2013-02-14 17:39:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1006045 Iridex Corp IRIX Electromedical & Electrotherapeutic Apparatus (3845) 770210467
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1422484 H James Mackaness 1212 Terra Bella Avenue
Mountain View CA 94043
Cfo And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-02-12 3,000 $2.49 5,000 No 4 M Direct
Common Stock Disposition 2013-02-12 3,000 $4.83 2,000 No 4 S Direct
Common Stock Acquisiton 2013-02-13 3,000 $2.49 5,000 No 4 M Direct
Common Stock Disposition 2013-02-13 3,000 $4.70 2,000 No 4 S Direct
Common Stock Acquisiton 2013-02-14 3,000 $2.49 5,000 No 4 M Direct
Common Stock Disposition 2013-02-14 3,000 $4.79 2,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Right to Buy Disposition 2013-02-12 3,000 $0.00 3,000 $2.49
Common Stock Stock Option Right to Buy Disposition 2013-02-13 3,000 $0.00 3,000 $2.49
Common Stock Stock Option Right to Buy Disposition 2013-02-14 3,000 $0.00 3,000 $2.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
62,000 2009-01-02 2015-01-02 No 4 M Direct
59,000 2009-01-02 2015-01-02 No 4 M Direct
56,000 2009-01-02 2015-01-02 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was pursuant to the Reporting Person's Rule 10b5-1 Selling Plan that was effective March 12, 2012.
  2. This option was granted pursuant to IRIDEX Corporation's incentive 1998 Stock Plan and is exempt pursuant to Rule 16b-3.
  3. The shares shall vest as follows: 12/48ths of the shares shall vest 12 months after the Vesting Commencement Date and 1/48th of the shares shall vest each month thereafter.